Absci and Caltech collaborate to accelerate affordable HIV therapeutic vaccine

On Aug. 10, 2023, drug creation company Absci Corporation (ABSI) announced that its collaborative effort with the California Institute of Technology (Caltech) has received a grant from the Bill & Melinda Gates foundation. Led by Dr. Pamela Bjorkman, the collaboration combines research capabilities and advanced technological expertise in structural biology,

MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)

Plus: Amphastar Pharmaceuticals files a patent for an intranasal pharmaceutical formulation with naloxone and bile acid. * MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial) * Adult participants with B-Cell Malignancies: A study to assess adverse events, change in disease activity, and how Oral ABBV-101 moves through the body. * Amphastar Pharmaceuticals

NYACSE: DSNKY - PDUFA date update

New Gene Therapy for Duchenne’s Approved

First Drug Ever for Friedrich’s Ataxia Approved

CRISPR Clinical Trials Ramp Up

Breast Cancer and BRCA1

Paraplegic man walks again with brain-spine bridge

Targeted Radiation to Fight Prostate Cancer

New Antibody Therapy for Head & Neck Cancer

Aerosolized Gene Therapy for Cystic Fibrosis

Targeted Cell Therapy for Pancreatic Cancer